Targeting neuroblastoma stem cells with retinoic acid and proteasome inhibitor.

Autores de IIS La Fe

• Yania Yañez Peralta

  Autor

• Sarai Palanca Suela

  Autor

• Adela Cañete Nieto

  Autor

• Victoria Castel Sánchez

  Autor

• Jaime Font De Mora Sainz

  Autor

Participantes ajenos a IIS La Fe

• Hämmerle B
• Burks DJ

Grupos

• Investigación Clínica y Traslacional en Cáncer

Abstract

Neuroblastma cell lines contain a side-population of cells which express stemness markers. These stem-like cells may represent the potential underlying mechanism for resistance to conventional therapy and recurrence of neuroblastoma in patients.